Lorna McInroy
Director, Clinical Biomarkers Moderna
Seminars
Tuesday 31st March 2026
Panel Discussion: Advancing Sample Management & Pre-Analytic Workflows for Robust, Reproducible Clinical Outcomes
4:50 pm
- How can early integration of a global-ready sample and biomarker strategy into clinical design reduce downstream risk of sample or data variability?
- What are the key approaches to harmonizing pre-analytical workflows, and how can they be controlled across multi-site operations?
- What innovations in digital tools are facilitating end-to-end integrity and reproducibility?
- How are sponsors ensuring consistency in biospecimen handling when working across multiple CROs or laboratory partners?
- What level of collaboration between translational scientists, clinicians, and data teams is needed to ensure biomarker hypotheses remain viable throughout trial execution?
Wednesday 1st April 2026
Building Resilient Biomarker Infrastructure: From Pandemic Preparedness to Clinical Testing Excellence
3:40 pm
- Accelerating biomarker delivery through integrated assay platforms – how Moderna’s UK Clinical Biomarker Laboratory is enabling rapid, compliant deployment of immunoassay, cytometry, and molecular methods for global clinical programs
- Embedding automation and AI in sample and data workflows – leveraging robotic biobanking, and digital traceability to enhance efficiency, reproducibility, and data integrity
- Pandemic preparedness and translational resilience – establishing high-containment and rapid-assay transfer capabilities to respond to emerging pathogens and future public-health challenges
